ChitogenX Inc.
CHNXF · OTC
10/31/2024 | 7/31/2024 | 4/30/2024 | 1/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $9 | $9 |
| Gross Profit | $0 | $0 | -$9 | -$9 |
| % Margin | – | – | – | – |
| R&D Expenses | $169 | $35 | $85 | $285 |
| G&A Expenses | $209 | $181 | $150 | $447 |
| SG&A Expenses | $209 | $181 | $35 | $449 |
| Sales & Mktg Exp. | $0 | $0 | -$115 | $2 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $378 | $216 | $120 | $734 |
| Operating Income | -$378 | -$216 | -$120 | -$743 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$228 | -$117 | -$37 | $283 |
| Pre-Tax Income | -$606 | -$333 | -$157 | -$458 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$606 | -$333 | -$157 | -$458 |
| % Margin | – | – | – | – |
| EPS | -0.007 | -0.004 | -0.002 | -0.006 |
| % Growth | -82.5% | -110.5% | 65.5% | – |
| EPS Diluted | -0.007 | -0.004 | -0.002 | -0.006 |
| Weighted Avg Shares Out | 83,130 | 83,156 | 83,156 | 83,130 |
| Weighted Avg Shares Out Dil | 83,130 | 83,130 | 83,130 | 83,130 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $23 |
| Interest Expense | $215 | $206 | $190 | $183 |
| Depreciation & Amortization | $9 | $9 | $9 | $10 |
| EBITDA | -$382 | -$118 | $14 | -$727 |
| % Margin | – | – | – | – |